Price history
¥1,266Latest+14.0%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview
Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
News
Key numbersShowing 8 of 20
PER
240.23How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.PBR
0.7How many times the company's net assets? Around 1x is generally considered a benchmark.ROE
0.3%Earning power. A figure above 10% is generally considered good.Dividend yield
0.0%The annual dividend as a percentage of the share price.Market capitalization
¥9.8bnShare price × number of shares. The value of the entire company.Equity ratio
66.4%The proportion of assets funded by money that does not have to be repaid.Operating margin
2.4%The percentage of revenue remaining from the company’s core business.Revenue growth (3 years)
6.0%The average annual growth in sales over the past three years.What to watch next
Expansion of pharmaceutical manufacturing equipment at the Izumo First Plant, scheduled for completion in June 2026, and confirmation of initial start-up results
From June 2026 onward, with the impact on utilization and orders/shipments expected over several quarters after completionImpact MediumLikelihood Medium
Pharmaceutical active pharmaceutical ingredient (API) manufacturing equipment at the KNC Bio Research Center, scheduled for completion in July 2025, followed by verification that operations have become established
During 2026, as the impact of operational stabilization and improvements in utilization and productivity is reflected in the financial resultsImpact MediumLikelihood Medium
Disclosure of progress in the mass-production sales ratio, utilization and bottleneck removal supporting expansion of the mass-production stage to above 60%
From 2026 onward, in line with earnings results and progress disclosuresImpact HighLikelihood Medium
What to watch next
Who owns itTop holders total 121.2%
Listed holders 121.2%Everyone else 0.0%
Total60.59%
KNC興産(株)19.53%
Miyauchi Hitoshi (宮内 仁志)10.50%
広瀬 克利9.35%
(公財)KNC広瀬財団9.04%
純正化學(株)3.10%
池谷 誠一2.86%
岩見 好爲2.04%
3 other listed holders4.17%
| Holder | Ownership (%) |
|---|---|
| Total | 60.59 |
| KNC興産(株) | 19.53 |
| Miyauchi Hitoshi (宮内 仁志) | 10.50 |
| 広瀬 克利 | 9.35 |
| (公財)KNC広瀬財団 | 9.04 |
| 純正化學(株) | 3.10 |
| 池谷 誠一 | 2.86 |
| 岩見 好爲 | 2.04 |
| 3 other listed holders | 4.17 |
This company's documents
Filings
Timely disclosures
- 2026-08-31Q&A on the Financial Results for the First Quarter of the Fiscal Year Ending March 2027
- 2026-08-10Notice Regarding Changes in Major Shareholders
- 2026-08-10Notice Regarding the Results of the Acquisition of Treasury Shares Through an Off-Auction Purchase (ToSTNeT-3) and Completion of the Acquisition
- 2026-08-07Notice Regarding the Acquisition of Treasury Shares and the Purchase of Treasury Shares through an Off-Auction Own-Share Purchase Transaction (ToSTNeT-3)
- 2026-08-07Notice of Completion of Payment for the Disposal of Treasury Shares as Restricted Stock Compensation
- 2026-08-07Supplementary Explanatory Materials for the First Quarter Financial Results for the Fiscal Year Ending March 2027
- 2026-08-07Notice Regarding the Publication of the Full-Year Earnings Forecast for the Fiscal Year Ending March 2027 and the Year-End Dividend Forecast
- 2026-08-07First-Quarter Financial Results for the Fiscal Year Ending March 2027 [Japanese GAAP] (Non-Consolidated)
9 more
- 2026-07-21Notice Concerning the Disposal of Treasury Shares as Restricted Stock Compensation
- 2026-07-21Notice Regarding Revisions to Full-Year Earnings Forecasts for the Fiscal Year Ending March 2027 (First Quarter)
- 2026-06-09Notification of Independent Officers
- 2026-06-02Notice of Convocation of the 42nd Annual General Meeting of Shareholders
- 2026-05-15Notice Regarding the Holding of a Financial Results Briefing
- 2026-05-14Business Plan and Growth Potential
- 2026-05-14Supplementary Financial Results Information for the Fiscal Year Ending March 2026
- 2026-05-14Summary of Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Non-consolidated)
- 2026-05-14Notice Regarding the Selection of Candidates for Director Positions